)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Cytek Biosciences (CTKB) investor relations material
Cytek Biosciences Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary5 Nov, 2025
Executive summary
Q3 2025 revenue reached $52.3 million, up 2% year-over-year, driven by APAC, US, and recurring revenue growth, while EMEA declined sharply due to reduced academic and government sales.
Net loss for Q3 2025 was $5.5 million, compared to net income of $0.9 million in Q3 2024, due to lower gross profit and higher operating expenses.
Recurring revenue from service and reagents grew 19%–21% year-over-year, reflecting a larger installed base and increased maintenance activity.
Installed base expanded by 161 instruments to 3,456 units; Aurora cell sorter grew 35% year-over-year.
European headquarters in Amsterdam expanded by over 40%, improving reagent logistics, customer service, and training.
Financial highlights
Product revenue decreased 4% year-over-year, with a 26% decline in EMEA offset by 19% growth in APAC; service revenue grew 19%.
GAAP gross profit was $27.6 million, down 5% year-over-year; gross margin was 53% (down from 56%).
Adjusted gross margin was 55%, down from 60% in Q3 2024.
Operating expenses rose 10%–11% to $36.7 million, mainly due to higher G&A expenses, including legal costs and a $0.7 million non-recurring write-off.
Adjusted EBITDA declined to $2.5 million from $7.6 million year-over-year; excluding investment income, adjusted EBITDA was $0.5 million.
Cash and marketable securities totaled $261.7 million at quarter-end.
Outlook and guidance
Full-year 2025 revenue guidance reaffirmed at $196–$205 million, assuming stable currency rates.
Management expects continued investment in R&D, commercial infrastructure, and geographic expansion, with expenses anticipated to rise.
Existing cash and anticipated cash flows are expected to meet working capital and capital expenditure needs for at least the next 12 months.
Expect continued strong growth in APAC, stable U.S. performance, and ongoing EMEA weakness.
Anticipate positive adjusted EBITDA in Q4 and continued momentum in recurring revenue.
EMEA decline: What specific recovery actions?
New instruments' 2026 growth contribution?
Leverage recurring revenue for profitability?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Cytek Biosciences earnings date
Piper Sandler 37th Annual Healthcare Conference3 Dec, 2025
Next Cytek Biosciences earnings date
Piper Sandler 37th Annual Healthcare Conference3 Dec, 2025
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Cytek Biosciences Inc. is a biotechnology company specializing in cell analysis solutions. The company develops and manufactures flow cytometry instruments, reagents, and software used in biomedical research and clinical diagnostics. Cytek’s technologies enable the study of cell characteristics, functions, and biomarkers, supporting research in immunology, oncology, and other areas of life sciences. The company serves academic institutions, pharmaceutical companies, and clinical laboratories, providing tools for advanced cellular analysis and discovery. The company is headquartered in Fremont, California, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage